NeuroOne Medical completed an initial animal implant of its novel thin film paddle leads for spinal cord stimulation. The devices are intended for the treatment of patients with chronic back pain due to multiple failed back surgery syndrome, intractable low back and leg pain. A mini laminectomy surgical approach was used to gain access to the epidural space for device placement. All devices were easily advanced to the target location in under one minute. A competitive silicone-based lead was also placed for comparison purposes. The NeuroOne lead fit comfortably in the epidural space and the veterinary surgeon reported no concerns regarding the placement of the lead.More testing will be completed to optimize the design and placement. The company is also developing a percutaneous paddle lead placement system which would eliminate the need for an incision in the patient’s back.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on NMTC:
- NeuroOne says it does not hold cash deposits, securities at Silicon Valley Bank
- NeuroOne Medical awarded U.S. patent relating to electrode technology
- NeuroOne Medical reports Q1 EPS (11c) vs. (18c) a year ago
- NeuroOne® Reports First Quarter Fiscal Year 2023 Financial Results and Provides Corporate Update